These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 17720460)

  • 21. The effect of a layer-by-layer chitosan-heparin coating on the endothelialization and coagulation properties of a coronary stent system.
    Meng S; Liu Z; Shen L; Guo Z; Chou LL; Zhong W; Du Q; Ge J
    Biomaterials; 2009 Apr; 30(12):2276-83. PubMed ID: 19168214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are impaired endothelial progenitor cells involved in the processes of late in-stent thrombosis and re-endothelialization of drug-eluting stents?
    Zhao FH; Chen YD; Jin ZN; Lu SZ
    Med Hypotheses; 2008; 70(3):512-4. PubMed ID: 17764856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Surface modification of endovascular stents with rosuvastatin and heparin-loaded biodegradable nanofibers by electrospinning.
    Janjic M; Pappa F; Karagkiozaki V; Gitas C; Ktenidis K; Logothetidis S
    Int J Nanomedicine; 2017; 12():6343-6355. PubMed ID: 28919738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surface modification of esophageal stent materials by a polyethylenimine layer aiming at anti-cancer function.
    Zhang K; Bai Y; Wang X; Li Q; Guan F; Li J
    J Mater Sci Mater Med; 2017 Aug; 28(8):125. PubMed ID: 28707137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mussel-inspired one-step adherent coating rich in amine groups for covalent immobilization of heparin: hemocompatibility, growth behaviors of vascular cells, and tissue response.
    Yang Y; Qi P; Wen F; Li X; Xia Q; Maitz MF; Yang Z; Shen R; Tu Q; Huang N
    ACS Appl Mater Interfaces; 2014 Aug; 6(16):14608-20. PubMed ID: 25105346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biofunctionalization of titanium surface with multilayer films modified by heparin-VEGF-fibronectin complex to improve endothelial cell proliferation and blood compatibility.
    Wang HG; Yin TY; Ge SP; Zhang Q; Dong QL; Lei DX; Sun DM; Wang GX
    J Biomed Mater Res A; 2013 Feb; 101(2):413-20. PubMed ID: 22865832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of coimmobilizing heparin and fibronectin on titanium on hemocompatibility and endothelialization.
    Li G; Yang P; Qin W; Maitz MF; Zhou S; Huang N
    Biomaterials; 2011 Jul; 32(21):4691-703. PubMed ID: 21463893
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Haemocompatibility improvement of metallic surfaces by covalent immobilization of heparin-liposomes.
    Kastellorizios M; Michanetzis GP; Pistillo BR; Mourtas S; Klepetsanis P; Favia P; Sardella E; d'Agostino R; Missirlis YF; Antimisiaris SG
    Int J Pharm; 2012 Aug; 432(1-2):91-8. PubMed ID: 22569232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The use of alkanethiol self-assembled monolayers on 316L stainless steel for coronary artery stent nanomedicine applications: an oxidative and in vitro stability study.
    Mahapatro A; Johnson DM; Patel DN; Feldman MD; Ayon AA; Agrawal CM
    Nanomedicine; 2006 Sep; 2(3):182-90. PubMed ID: 17292141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tailoring of the titanium surface by immobilization of heparin/fibronectin complexes for improving blood compatibility and endothelialization: an in vitro study.
    Li G; Yang P; Liao Y; Huang N
    Biomacromolecules; 2011 Apr; 12(4):1155-68. PubMed ID: 21332186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heparin/poly-l-lysine nanoplatform with growth factor delivery for surface modification of cardiovascular stents: The influence of vascular endothelial growth factor loading.
    Tan J; Cui Y; Zeng Z; Wei L; Li L; Wang H; Hu H; Liu T; Huang N; Chen J; Weng Y
    J Biomed Mater Res A; 2020 Jun; 108(6):1295-1304. PubMed ID: 32064767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective adhesion and growth of vascular endothelial cells on bioactive peptide nanofiber functionalized stainless steel surface.
    Ceylan H; Tekinay AB; Guler MO
    Biomaterials; 2011 Dec; 32(34):8797-805. PubMed ID: 21885121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fabrication of alternating polycation and albumin multilayer coating onto stainless steel by electrostatic layer-by-layer adsorption.
    Ji J; Tan Q; Fan DZ; Sun FY; Barbosa MA; Shen J
    Colloids Surf B Biointerfaces; 2004 Apr; 34(3):185-90. PubMed ID: 15261073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heparin/collagen multilayer as a thromboresistant and endothelial favorable coating for intravascular stent.
    Lin Q; Yan J; Qiu F; Song X; Fu G; Ji J
    J Biomed Mater Res A; 2011 Jan; 96(1):132-41. PubMed ID: 21105161
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelialization of sirolimus-eluting stents with slow and extended drug release in the porcine overstretch model.
    Frey D; Billinger M; Meier P; Beslac O; Grossenbacher R; Hänni B; Hess OM
    J Invasive Cardiol; 2008 Dec; 20(12):631-4. PubMed ID: 19057024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In-vitro hemocompatibility evaluation of a thermoplastic polyurethane membrane with surface-immobilized water-soluble chitosan and heparin.
    Lin WC; Tseng CH; Yang MC
    Macromol Biosci; 2005 Oct; 5(10):1013-21. PubMed ID: 16211549
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immobilization of heparin/poly-(L)-lysine nanoparticles on dopamine-coated surface to create a heparin density gradient for selective direction of platelet and vascular cells behavior.
    Liu T; Liu Y; Chen Y; Liu S; Maitz MF; Wang X; Zhang K; Wang J; Wang Y; Chen J; Huang N
    Acta Biomater; 2014 May; 10(5):1940-54. PubMed ID: 24342042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation, characterization and anticoagulation of curcumin-eluting controlled biodegradable coating stents.
    Pan ChJ; Tang JJ; Weng YJ; Wang J; Huang N
    J Control Release; 2006 Nov; 116(1):42-9. PubMed ID: 17046093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coronary in-stent restenosis in diabetic patients after implantation of sirolimus or paclitaxel drug-eluting coronary stents.
    Kitoga M; Pasquet A; Preumont V; Kefer J; Hermans MP; Vanoverschelde JL; Buysschaert M
    Diabetes Metab; 2008 Feb; 34(1):62-7. PubMed ID: 18069029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preparation and surface characterization of HMDI-activated 316L stainless steel for coronary artery stents.
    Chuang TW; Chen MH; Lin FH
    J Biomed Mater Res A; 2008 Jun; 85(3):722-30. PubMed ID: 17896759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.